Contraceptives effect on exercise induced hypoalgesia

Summary

We are conducting a research study examining how hormonal contraceptives alters pain perception and muscle function before and after constant load exercise. In a total of 5 visits, you will perform constant load exercise and tests to determine pain perception and muscle function. The tests will be brief (~ 1.5 hour for each visit), and are not dangerous.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 45

Accepts healthy participants: Yes

Inclusion criteria:

We are seeking healthy, recreationally active males and females aged 18-45 years.

Exclusion criteria:

You will be ineligible if you:
- use hormonal contraceptives other than a combined, monophasic oral contraceptive pill or Mirena hormonal intrauterine device
- previously had a brain injury (e.g., concussion)
- are obese (BMI >30 kg/m^2)
- are a smoker
- currently have a mood, neurological, cardiovascular, and/or metabolic disorder
- had a lower limb injury within the past 6 months that currently affects your ability to exercise, particularly the knee joint

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Brooklyn Wiggins

Principal investigator:

Saied Jalal Aboodarda

Clinical trial:

No

REB-ID:

REB22-0936